Tasigna Clinical Trials Tasigna RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia
Condition:   Leukemia Intervention:   Other: No Intervention Sponsor:   Takeda Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2023 Category: Research Source Type: clinical trials

Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line
Condition:   Chronic Myeloid Leukemia Intervention:   Other: Nilotinib Sponsor:   Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2023 Category: Research Source Type: clinical trials